| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
|---|
| What is an ATC-Code? | ATC-Overview |
|
| | | IP | CI | | Requip-Modutab 2 mg | 28 Tablet(s) | 17.76 | 35.65 | 10 % | | Tabletten mit veränderter Wirkstofffreisetzung: Ropinirolum 2 mg | GlaxoSmithKline AG | B / SL / SO | FB | | G |  |
| | | IP | CI | | Requip-Modutab 4 mg | 28 Tablet(s) | 31.58 | 50.60 | 10 % | | Tabletten mit veränderter Wirkstofffreisetzung: Ropinirolum 4 mg | GlaxoSmithKline AG | B / SL / SO | FB | | G | |
| | | IP | CI | | Requip-Modutab 8 mg | 28 Tablet(s) | 52.47 | 73.20 | 10 % | | Tabletten mit veränderter Wirkstofffreisetzung: Ropinirolum 8 mg | GlaxoSmithKline AG | B / SL / SO | FB | | G | |
| | | IP | CI | | Ropinirol-Mepha retard 2 mg | 28 Tablet(s) | 16.16 | 34.00 | 10 % | | Delayed release tablets: Ropinirolum 2 mg | Mepha Pharma AG | ● B / SL / SG | FB | | G | |
| | | IP | CI | | Ropinirol-Mepha retard 4 mg | 28 Tablet(s) | 28.72 | 47.65 | 10 % | | Delayed release tablets: Ropinirolum 4 mg | Mepha Pharma AG | ● B / SL / SG | FB | | G | |
| | | IP | CI | | Ropinirol-Mepha retard 8 mg | 28 Tablet(s) | 47.71 | 68.30 | 10 % | | Delayed release tablets: Ropinirolum 8 mg | Mepha Pharma AG | ● B / SL / SG | FB | | G | |
| | | IP | CI | | Ropinirol Sandoz Retard 2 mg | 28 Tablet(s) | 16.50 | 34.35 | 10 % | | Tablette mit veränderter Wirkstofffreisetzung: Ropinirolum 2 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Ropinirol Sandoz Retard 4 mg | 28 Tablet(s) | 29.31 | 48.25 | 10 % | | Tablette mit veränderter Wirkstofffreisetzung: Ropinirolum 4 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Ropinirol Sandoz Retard 8 mg | 28 Tablet(s) | 47.71 | 68.30 | 10 % | | Tablette mit veränderter Wirkstofffreisetzung: Ropinirolum 8 mg | Sandoz
Pharmaceuticals AG | ● B / SL / SG | FB | | G | |
| L | | IP | CI | | Adartrel 0,25 mg | 12 Tablet(s) | 2.70 | 12.15 | 10 % | | Coated tablets: Ropinirolum | GlaxoSmithKline AG | B / SL | FB | | G | |
| L | | IP | CI | | Adartrel 0,5 mg | 84 Tablet(s) | 15.00 | 32.75 | 10 % | | Coated tablets: Ropinirolum | GlaxoSmithKline AG | B / SL | FB | | G | |
| L | | IP | CI | | Adartrel 2,0 mg | 84 Tablet(s) | 49.19 | 69.90 | 10 % | | Coated tablets: Ropinirolum 2 mg | GlaxoSmithKline AG | B / SL | FB | | G | |
| | | IP | CI | | Requip 0,25 mg | 21 Tablet(s) | 2.78 | 12.25 | 10 % | | Coated tablets: Ropinirolum | GlaxoSmithKline AG | B / SL | FB | | G | |
| | | IP | CI | | Requip 1,0 mg | 84 Tablet(s) | 31.65 | 50.85 | 10 % | | Coated tablets: Ropinirolum 1 mg | GlaxoSmithKline AG | B / SL | FB | | G | |
| | | IP | CI | | Requip 2,0 mg | 84 Tablet(s) | 56.30 | 77.65 | 10 % | | Coated tablets: Ropinirolum 2 mg | GlaxoSmithKline AG | B / SL | FB | | G | |
| | | IP | CI | | Requip 5,0 mg | 84 Tablet(s) | 118.95 | 145.80 | 10 % | | Coated tablets: Ropinirolum 5 mg | GlaxoSmithKline AG | B / SL | FB | | G | |
| | | IP | CI | | Ropinirol-Mepha retard 2 mg | 21 Tablet(s) | PR | PR | k.A. | | Delayed release tablets: Ropinirolum 2 mg | Mepha Pharma AG | B | FB | | G | |
|
| L | | IP | CI | | Sifrol ER 0,375 mg | 10 Tablet(s) | 5.33 | 15.00 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum | Boehringer Ingelheim
(Schweiz) GmbH | B / SL / SO | FB | | G | |
| L | | IP | CI | | Sifrol ER 0,75 mg | 10 Tablet(s) | 9.85 | 27.05 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum | Boehringer Ingelheim
(Schweiz) GmbH | B / SL / SO | FB | | G | |
| L | | IP | CI | | Sifrol ER 0,75 mg | 30 Tablet(s) | 27.52 | 46.10 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum | Boehringer Ingelheim
(Schweiz) GmbH | B / SL / SO | FB | | G | |
| L | | IP | CI | | Sifrol ER 1,5 mg | 30 Tablet(s) | 55.03 | 75.75 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 1.5 mg | Boehringer Ingelheim
(Schweiz) GmbH | B / SL / SO | FB | | G | |
| L | | IP | CI | | Sifrol ER 3,0 mg | 30 Tablet(s) | 110.06 | 135.10 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 3 mg | Boehringer Ingelheim
(Schweiz) GmbH | B / SL / SO | FB | | G | |
| L | | IP | CI | | Sifrol ER 4,5 mg | 30 Tablet(s) | 165.09 | 194.45 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 4.5 mg | Boehringer Ingelheim
(Schweiz) GmbH | B / SL / SO | FB | | G | |
| | | IP | CI | | Sifrol 0,125 mg - T | 30 Tablet(s) | 7.14 | 16.85 | 20 % | | Tablets: Pramipexoli Dihydrochloridum Monohydricum | Boehringer Ingelheim
(Schweiz) GmbH | B / SL / SO | FB | | G | |
| | | IP | CI | | Sifrol 0,25 mg - T | 30 Tablet(s) | 13.17 | 30.65 | 20 % | | Tablets: Pramipexoli Dihydrochloridum Monohydricum | Boehringer Ingelheim
(Schweiz) GmbH | B / SL / SO | FB | | G | |
| | | IP | CI | | Sifrol 0,25 mg - T | 100 Tablet(s) | 40.88 | 60.40 | 20 % | | Tablets: Pramipexoli Dihydrochloridum Monohydricum | Boehringer Ingelheim
(Schweiz) GmbH | B / SL / SO | FB | | G | |
| | | IP | CI | | Sifrol 0,5 mg | 100 Tablet(s) | 81.90 | 103.20 | 20 % | | Tablets: Pramipexoli Dihydrochloridum Monohydricum | Boehringer Ingelheim
(Schweiz) GmbH | B / SL / SO | FB | | G | |
| | | IP | CI | | Sifrol 1,0 mg | 100 Tablet(s) | 163.33 | 191.05 | 20 % | | Tablets: Pramipexoli Dihydrochloridum Monohydricum 1 mg | Boehringer Ingelheim
(Schweiz) GmbH | B / SL / SO | FB | | G | |
| L | | IP | CI | | Pramipexol ER Sandoz
0.375 mg | 10 | 4.53 | 14.15 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum | Sandoz
Pharmaceuticals AG | ● B / SL / SG | FB | | G | |
| L | | IP | CI | | Pramipexol ER Sandoz 0.75 mg | 10 | 8.38 | 25.55 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| L | | IP | CI | | Pramipexol ER Sandoz 0.75 mg | 30 | 23.39 | 41.85 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum | Sandoz
Pharmaceuticals AG | ● B / SL / SG | FB | | G | |
| L | | IP | CI | | Pramipexol ER Sandoz 1.5 mg | 30 | 46.78 | 67.30 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 1.5 mg | Sandoz
Pharmaceuticals AG | ● B / SL / SG | FB | | G | |
| L | | IP | CI | | Pramipexol ER Sandoz 3 mg | 30 | 93.57 | 118.20 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 3 mg | Sandoz
Pharmaceuticals AG | ● B / SL / SG | FB | | G | |
| L | | IP | CI | | Pramipexol ER Sandoz 4.5 mg | 30 | 140.36 | 169.05 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 4.5 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| L | | IP | CI | | Pramipexol ER Zentiva
0.375 mg | 10 | 4.53 | 14.15 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum | Helvepharm AG | ● B / SL / SG | FB | | G | |
| L | | IP | CI | | Pramipexol ER Zentiva
0.75 mg | 10 | 8.38 | 25.55 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum | Helvepharm AG | B / SL / SG | FB | | G | |
| L | | IP | CI | | Pramipexol ER Zentiva
0.75 mg | 30 | 23.39 | 41.85 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum | Helvepharm AG | ● B / SL / SG | FB | | G | |
| L | | IP | CI | | Pramipexol ER Zentiva 1.5 mg | 30 | 46.78 | 67.30 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 1.5 mg | Helvepharm AG | B / SL / SG | FB | | G | |
| L | | IP | CI | | Pramipexol ER Zentiva 3.0 mg | 30 | 93.56 | 118.15 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 3 mg | Helvepharm AG | B / SL / SG | FB | | G | |
| L | | IP | CI | | Pramipexol ER Zentiva 4.5 mg | 30 | 140.34 | 169.05 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 4.5 mg | Helvepharm AG | B / SL / SG | FB | | G | |
| L | | IP | CI | | Pramipexol-Mepha ER 0.375 mg | 10 | 4.53 | 14.15 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum | Mepha Pharma AG | B / SL / SG | FB | | G | |
| L | | IP | CI | | Pramipexol-Mepha ER 0.75 mg | 10 | 8.38 | 25.55 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum | Mepha Pharma AG | B / SL / SG | FB | | G | |
| L | | IP | CI | | Pramipexol-Mepha ER 0.75 mg | 30 | 23.39 | 41.85 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum | Mepha Pharma AG | B / SL / SG | FB | | G | |
| L | | IP | CI | | Pramipexol-Mepha ER 1.5 mg | 30 | 46.78 | 67.30 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 1.5 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| L | | IP | CI | | Pramipexol-Mepha ER 3 mg | 30 | 93.56 | 118.15 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 3 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| L | | IP | CI | | Pramipexol-Mepha ER 4.5 mg | 30 | 140.34 | 169.05 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 4.5 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Pramipexol Spirig HC
0.125 mg | 30 | 4.99 | 14.65 | 10 % | | Tablets: Pramipexoli Dihydrochloridum Monohydricum | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | | | Pramipexol Spirig HC 0.25 mg | 30 | 11.26 | 28.70 | 10 % | | Tablets: Pramipexoli Dihydrochloridum Monohydricum | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | | | Pramipexol Spirig HC 0.25 mg | 100 | 33.34 | 52.70 | 10 % | | Tablets: Pramipexoli Dihydrochloridum Monohydricum | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | | | Pramipexol Spirig HC 0.5 mg | 100 | 44.88 | 65.20 | 10 % | | Tablets: Pramipexoli Dihydrochloridum Monohydricum | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | | | Pramipexol Spirig HC 1 mg | 100 | 114.56 | 141.00 | 10 % | | Tablets: Pramipexoli Dihydrochloridum Monohydricum 1 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Pramipexol Zentiva 0.125 mg | 30 | 4.98 | 14.65 | 10 % | | Tablets: Pramipexoli Dihydrochloridum Monohydricum | Helvepharm AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Pramipexol Zentiva 0.25 mg | 30 | 11.99 | 29.45 | 10 % | | Tablets: Pramipexoli Dihydrochloridum Monohydricum | Helvepharm AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Pramipexol Zentiva 0.25 mg | 100 | 33.34 | 52.70 | 10 % | | Tablets: Pramipexoli Dihydrochloridum Monohydricum | Helvepharm AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Pramipexol Zentiva 0.5 mg | 100 | 44.83 | 65.15 | 10 % | | Tablets: Pramipexoli Dihydrochloridum Monohydricum | Helvepharm AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Pramipexol Zentiva 1.0 mg | 100 | 114.56 | 141.00 | 10 % | | Tablets: Pramipexoli Dihydrochloridum Monohydricum 1 mg | Helvepharm AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Pramipexol-Mepha 0.125 mg | 30 | 4.98 | 14.65 | 10 % | | Tablets: Pramipexoli Dihydrochloridum Monohydricum | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Pramipexol-Mepha 0.25 mg | 30 | 11.82 | 29.25 | 10 % | | Tablets: Pramipexoli Dihydrochloridum Monohydricum | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Pramipexol-Mepha 0.25 mg | 100 | 33.33 | 52.65 | 10 % | | Tablets: Pramipexoli Dihydrochloridum Monohydricum | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Pramipexol-Mepha 0.5 mg | 100 | 44.80 | 65.15 | 10 % | | Tablets: Pramipexoli Dihydrochloridum Monohydricum | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Pramipexol-Mepha 1.0 mg | 100 | 114.50 | 140.95 | 10 % | | Tablets: Pramipexoli Dihydrochloridum Monohydricum 1 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | | | Pramipexol Spirig HC 1.5 mg | 100 | PR | PR | k.A. | | Tablets: Pramipexoli Dihydrochloridum Monohydricum 1.5 mg | Spirig HealthCare AG | B | FB | | G | |
|
| | | IP | CI | | Cabaser 1 mg | 20 | 36.82 | 58.75 | k.A. | | Tablets: Cabergolinum 1 mg | Pfizer AG | B | FB | | G | |
| | | IP | CI | | Cabaser 2 mg | 20 | 47.29 | 70.75 | k.A. | | Tablets: Cabergolinum 2 mg | Pfizer AG | B | FB | | G | |
|
| L | | IP | CI | | Dacepton 5 mg/ml | 5 x 20 ml | 173.78 | 205.40 | 10 % | | Infusion solution: Apomorphini Hydrochloridum Hemihydricum 5 mg/ml | Medius AG | B / SL | FB | | G | |
| L | | IP | CI | | APO-go 50 mg/10 ml | 5 Fertigspritze(n) | 86.89 | 110.90 | 10 % | | Infusionslösung in einer Fertigspritze: Apomorphini Hydrochloridum Hemihydricum 50 mg | Spirig HealthCare AG | B / SL | FB | | G | |
| L | | IP | CI | | APO-go 100mg/20ml | 5 x 20 ml | 149.45 | 178.95 | 10 % | | Infusionslösung in einer Patrone: Apomorphini Hydrochloridum Hemihydricum 5 mg/ml | Spirig HealthCare AG | B / SL | FB | | G | |
| L | | IP | CI | | APO-go 10 mg/ml | 5 | 139.55 | 168.20 | 10 % | | Injektionslösung in einem Pen: Apomorphini Hydrochloridum Hemihydricum 10 mg | Spirig HealthCare AG | B / SL | FB | | G | |
| L | | IP | CI | | Dacepton 10 mg/ml | 5 x 3 ml | 139.55 | 168.20 | 10 % | | Injektionslösung in einer Patrone: Apomorphini Hydrochloridum Hemihydricum 10 mg/ml | Medius AG | B / SL | FB | | G | |
| | | IP | CI | | Apomorphin HCI Amino
10mg/ml | 10 | PR | PR | k.A. | | Injection solution: Apomorphini Hydrochloridum Hemihydricum 10 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | | G | |
| | | IP | CI | | Apomorphin HCI Amino
10mg/ml | 10 | PR | PR | k.A. | | Injection solution: Apomorphini Hydrochloridum Hemihydricum 10 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | | G | |
| | | IP | CI | | Apomorphin HCI Amino
10mg/ml | 100 | PR | PR | k.A. | | Injection solution: Apomorphini Hydrochloridum Hemihydricum 10 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | B | FB | | G | |
| | | IP | CI | | APO-go 50 mg/10 ml | 10 Fertigspritze(n) | PR | PR | k.A. | | Infusionslösung in einer Fertigspritze: Apomorphini Hydrochloridum Hemihydricum 50 mg | Spirig HealthCare AG | B | FB | | G | |
| | | IP | CI | | APO-go 10 mg/ml | | PR | PR | k.A. | | Injektionslösung in einem Pen: Apomorphini Hydrochloridum Hemihydricum 10 mg | Spirig HealthCare AG | B | FB | | G | |
| | | IP | CI | | APO-go 10 mg/ml | 10 | PR | PR | k.A. | | Injektionslösung in einem Pen: Apomorphini Hydrochloridum Hemihydricum 10 mg | Spirig HealthCare AG | B | FB | | G | |
| | | IP | CI | | Dacepton 10 mg/ml | 30 x 3 ml | PR | PR | k.A. | | Injektionslösung in einer Patrone: Apomorphini Hydrochloridum Hemihydricum 10 mg/ml | Medius AG | B | FB | | G | |
| | | IP | | | Apomorphinium chloratum
Streuli 2 mg/mL | 10 ampoule(s) | PR | PR | k.A. | | Injection solution: Apomorphini Hydrochloridum 2 mg | G. Streuli & Co. AG | B | FB | | G | |
| | | IP | | | Apomorphinium chloratum
Streuli 5 mg/mL | 10 ampoule(s) | PR | PR | k.A. | | Injection solution: Apomorphini Hydrochloridum 5 mg | G. Streuli & Co. AG | B | FB | | G | |
| | | IP | | | Apomorphinium chloratum
Streuli 10 mg/mL | 10 ampoule(s) | PR | PR | k.A. | | Injection solution: Apomorphini Hydrochloridum 10 mg | G. Streuli & Co. AG | B | FB | | G | |
|
| L | SIP | IP | CI | | Neupro 1 mg/24h | 7 | 10.65 | 28.00 | 10 % | | | UCB-Pharma SA | B / SL | FB | | G | |
| L | SIP | IP | CI | | Neupro 2 mg/24h | 7 | 16.60 | 34.45 | 10 % | | | UCB-Pharma SA | B / SL | FB | | G | |
| L | SIP | IP | CI | | Neupro 3 mg/24h | 7 | 16.66 | 34.55 | 10 % | | | UCB-Pharma SA | B / SL | FB | | G | |
| L | SIP | IP | CI | | Neupro 4 mg/24h | 7 | 27.22 | 46.00 | 10 % | | | UCB-Pharma SA | B / SL | FB | | G | |
| L | SIP | IP | CI | | Neupro 6 mg/24h | 7 | 30.29 | 49.35 | 10 % | | | UCB-Pharma SA | B / SL | FB | | G | |
| L | SIP | IP | CI | | Neupro 1 mg/24h | 28 | 34.94 | 54.40 | 10 % | | | UCB-Pharma SA | B / SL | FB | | G | |
| L | SIP | IP | CI | | Neupro 2 mg/24h | 28 | 54.44 | 75.60 | 10 % | | | UCB-Pharma SA | B / SL | FB | | G | |
| L | SIP | IP | CI | | Neupro 3 mg/24h | 28 | 54.62 | 75.80 | 10 % | | | UCB-Pharma SA | B / SL | FB | | G | |
| L | SIP | IP | CI | | Neupro 4 mg/24h | 28 | 89.27 | 113.50 | 10 % | | | UCB-Pharma SA | B / SL | FB | | G | |
| L | SIP | IP | CI | | Neupro 6 mg/24h | 28 | 99.33 | 124.45 | 10 % | | | UCB-Pharma SA | B / SL | FB | | G | |
| L | SIP | IP | CI | | Neupro 8 mg/24h | 28 | 121.99 | 149.10 | 10 % | | | UCB-Pharma SA | B / SL | FB | | G | |
